Exclusive

Publication

Byline

Location

US Patent Issued to Vanda Pharmaceuticals on July 7 for "Treatment of atopic dermatitis with tradipitant" (Maryland Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,055, issued on July 7, was assigned to Vanda Pharmaceuticals Inc. (Washington). "Treatment of atopic dermatitis with tradipitant" was invent... Read More


US Patent Issued to Gulch Pharma on July 7 for "Oral formulation comprising a crystalline form of rabeximod" (Swedish Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,056, issued on July 7, was assigned to Gulch Pharma AB (Sollentuna, Sweden). "Oral formulation comprising a crystalline form of rabeximod" w... Read More


US Patent Issued to Cedars-Sinai Medical Center on July 7 for "RIPK2 inhibition for the treatment of cancer" (California Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,057, issued on July 7, was assigned to Cedars-Sinai Medical Center (Los Angeles). "RIPK2 inhibition for the treatment of cancer" was invente... Read More


US Patent Issued to ATTAIN HEALTH on July 7 for "Methods and compositions to increase hair growth and/or prevent hair loss" (Georgia Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,058, issued on July 7, was assigned to ATTAIN HEALTH INC. (Dalton, Ga.). "Methods and compositions to increase hair growth and/or prevent ha... Read More


US Patent Issued to Resverlogix on July 7 for "Methods for improving renal function with a combination of a bet bromodomain inhibitor and a sodium dependent glucose transport 2 inhibitor" (Canadian Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,059, issued on July 7, was assigned to Resverlogix Corp. (Calgary, Canada). "Methods for improving renal function with a combination of a be... Read More


US Patent Issued to St. Jude Children's Research Hospital on July 7 for "Composition and methods for treating respiratory diseases" (Tennessee Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,060, issued on July 7, was assigned to St. Jude Children's Research Hospital (Memphis, Tenn.). "Composition and methods for treating respira... Read More


US Patent Issued to NANJING CHIA TAI TIANQING PHARMACEUTICAL on July 7 for "Unit dosage composition of AKT inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,061, issued on July 7, was assigned to NANJING CHIA TAI TIANQING PHARMACEUTICAL Co. LTD. (Nanjing, China). "Unit dosage composition of AKT i... Read More


US Patent Issued to Senhwa Biosciences on July 7 for "Combination therapy of tetracyclic quinolone analogs for treating cancer" (California Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,062, issued on July 7, was assigned to Senhwa Biosciences Inc. (New Taipei City, Taiwan). "Combination therapy of tetracyclic quinolone anal... Read More


US Patent Issued to The Schepens Eye Research Institute on July 7 for "Methods and materials for treatment of fibrosis" (Massachusetts Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,063, issued on July 7, was assigned to The Schepens Eye Research Institute Inc. (Boston). "Methods and materials for treatment of fibrosis" ... Read More


US Patent Issued to POLYACTIVA on July 7 for "Biodegradable drug-polymer conjugate" (Australian, British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,064, issued on July 7, was assigned to POLYACTIVA PTY LTD (Melbourne, Australia). "Biodegradable drug-polymer conjugate" was invented by Ste... Read More